INVESQUE INC (IVQ.CA) Fundamental Analysis & Valuation

TSX:IVQ • CA46136U1030

Current stock price

0.13 CAD
-0.01 (-3.7%)
Last:

This IVQ.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. IVQ.CA Profitability Analysis

1.1 Basic Checks

  • In the past year IVQ has reported negative net income.
  • In the past year IVQ has reported a negative cash flow from operations.
  • IVQ had negative earnings in each of the past 5 years.
  • Each year in the past 5 years IVQ had a positive operating cash flow.
IVQ.CA Yearly Net Income VS EBIT VS OCF VS FCFIVQ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -18.18%, IVQ is doing worse than 82.76% of the companies in the same industry.
  • With a Return On Equity value of -33.54%, IVQ is not doing good in the industry: 82.76% of the companies in the same industry are doing better.
  • IVQ has a Return On Invested Capital of 8.74%. This is amongst the best in the industry. IVQ outperforms 86.21% of its industry peers.
  • IVQ had an Average Return On Invested Capital over the past 3 years of 4.96%. This is significantly below the industry average of 18.70%.
  • The last Return On Invested Capital (8.74%) for IVQ is above the 3 year average (4.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -18.18%
ROE -33.54%
ROIC 8.74%
ROA(3y)-7.36%
ROA(5y)-7.06%
ROE(3y)-39.46%
ROE(5y)-37.07%
ROIC(3y)4.96%
ROIC(5y)3.58%
IVQ.CA Yearly ROA, ROE, ROICIVQ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • Looking at the Operating Margin, with a value of 14.18%, IVQ is in line with its industry, outperforming 41.38% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IVQ has declined.
  • The Gross Margin of IVQ (38.43%) is worse than 65.52% of its industry peers.
  • IVQ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.18%
PM (TTM) N/A
GM 38.43%
OM growth 3Y-11.85%
OM growth 5Y-19.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.87%
GM growth 5Y-10.41%
IVQ.CA Yearly Profit, Operating, Gross MarginsIVQ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. IVQ.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IVQ is still creating some value.
  • Compared to 1 year ago, IVQ has more shares outstanding
  • The number of shares outstanding for IVQ has been increased compared to 5 years ago.
  • The debt/assets ratio for IVQ has been reduced compared to a year ago.
IVQ.CA Yearly Shares OutstandingIVQ.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
IVQ.CA Yearly Total Debt VS Total AssetsIVQ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • IVQ has an Altman-Z score of -2.27. This is a bad value and indicates that IVQ is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -2.27, IVQ is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
  • IVQ has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.34, IVQ is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z -2.27
ROIC/WACC1.33
WACC6.57%
IVQ.CA Yearly LT Debt VS Equity VS FCFIVQ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

  • IVQ has a Current Ratio of 1.88. This is a normal value and indicates that IVQ is financially healthy and should not expect problems in meeting its short term obligations.
  • IVQ's Current ratio of 1.88 is amongst the best of the industry. IVQ outperforms 82.76% of its industry peers.
  • IVQ has a Quick Ratio of 1.88. This is a normal value and indicates that IVQ is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of IVQ (1.88) is better than 82.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
IVQ.CA Yearly Current Assets VS Current LiabilitesIVQ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

3. IVQ.CA Growth Analysis

3.1 Past

  • IVQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.12%, which is quite impressive.
  • The Revenue for IVQ has decreased by -36.01% in the past year. This is quite bad
  • IVQ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.50% yearly.
EPS 1Y (TTM)89.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.11%
Revenue 1Y (TTM)-36.01%
Revenue growth 3Y-5.05%
Revenue growth 5Y2.5%
Sales Q2Q%-84.53%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVQ.CA Yearly Revenue VS EstimatesIVQ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IVQ.CA Yearly EPS VS EstimatesIVQ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 0.2 0.4 0.6

1

4. IVQ.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • IVQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVQ.CA Price Earnings VS Forward Price EarningsIVQ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVQ indicates a rather cheap valuation: IVQ is cheaper than 96.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.43
IVQ.CA Per share dataIVQ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. IVQ.CA Dividend Analysis

5.1 Amount

  • No dividends for IVQ!.
Industry RankSector Rank
Dividend Yield 0%

IVQ.CA Fundamentals: All Metrics, Ratios and Statistics

INVESQUE INC

TSX:IVQ (3/27/2026, 7:00:00 PM)

0.13

-0.01 (-3.7%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-12
Earnings (Next)05-13
Inst Owners85.7%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap118.76M
Revenue(TTM)112.25M
Net Income(TTM)-32.72M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 0.88
EV/EBITDA 5.43
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.17
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.18%
ROE -33.54%
ROCE 12.13%
ROIC 8.74%
ROICexc 9.81%
ROICexgc 9.81%
OM 14.18%
PM (TTM) N/A
GM 38.43%
FCFM N/A
ROA(3y)-7.36%
ROA(5y)-7.06%
ROE(3y)-39.46%
ROE(5y)-37.07%
ROIC(3y)4.96%
ROIC(5y)3.58%
ROICexc(3y)5.27%
ROICexc(5y)3.77%
ROICexgc(3y)5.27%
ROICexgc(5y)3.77%
ROCE(3y)6.89%
ROCE(5y)4.97%
ROICexgc growth 3Y49.36%
ROICexgc growth 5Y22.64%
ROICexc growth 3Y49.36%
ROICexc growth 5Y22.64%
OM growth 3Y-11.85%
OM growth 5Y-19.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.87%
GM growth 5Y-10.41%
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 1.63
Cap/Depr 79.76%
Cap/Sales 3.2%
Interest Coverage 0.5
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z -2.27
F-Score4
WACC6.57%
ROIC/WACC1.33
Cap/Depr(3y)37.85%
Cap/Depr(5y)34.19%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.01%
Revenue growth 3Y-5.05%
Revenue growth 5Y2.5%
Sales Q2Q%-84.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.29%
EBIT growth 3Y-16.3%
EBIT growth 5Y-17.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1669%
FCF growth 3Y-26.54%
FCF growth 5YN/A
OCF growth 1Y-250.48%
OCF growth 3Y-20.82%
OCF growth 5Y-10.52%

INVESQUE INC / IVQ.CA Fundamental Analysis FAQ

What is the fundamental rating for IVQ stock?

ChartMill assigns a fundamental rating of 2 / 10 to IVQ.CA.


What is the valuation status for IVQ stock?

ChartMill assigns a valuation rating of 1 / 10 to INVESQUE INC (IVQ.CA). This can be considered as Overvalued.


What is the profitability of IVQ stock?

INVESQUE INC (IVQ.CA) has a profitability rating of 2 / 10.


What is the financial health of INVESQUE INC (IVQ.CA) stock?

The financial health rating of INVESQUE INC (IVQ.CA) is 4 / 10.